NCT05919095View on ClinicalTrials.gov

A Clinical Study of a Preoperative Translational Therapy for Unresectable Gallbladder Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
Unresectable Gallbladder Cancer
Interventions
DRUG

Carrilizumab plus GEMOX

"PD-1 antibody，200mg，D1，intravenous infusion, the administration time is 60 (+15) minutes.~GEMOX chemotherapy : gemcitabine 1000mg/m2,D1，D8；oxaliplatin 100mg/m2,D1intravenous infusion.Three weeks is a course of treatment."

Trial Locations (1)

376032

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER